Table 1 Baseline characteristics
From: Digital consults in heart failure care: a randomized controlled trial
DC group | Usual care | |
|---|---|---|
n | 78 | 72 |
Male sex (n, %) | 58 (74.4) | 53 (73.6) |
Age (years, median (IQR)) | 67.5 (59.3, 74.8) | 71.0 (58.0, 76.3) |
BMI (kg m-2, median (IQR)) | 26.6 (23.9, 31.4) | 26.0 (23.7, 28.5) |
Systolic BP (mmHG, median (IQR)) | 123.0 (112.0, 137.0) | 128.0 (108.8, 137.3) |
NYHA baseline (n, %) | ||
II | 58 (74.3) | 56 (78,8) |
III | 20 (25.6) | 15 (21.1) |
Cause of heart failure (n, %) | ||
Ischemic cardiomyopathy | 36 (46.2) | 37 (51.4) |
Non-ischemic cardiomyopathy | 42 (53.8) | 35 (48.6) |
Laboratory values | ||
Potassium (mmol l−1, mean (s.d.)) | 4.27 (0.47) | 4.25 (0.44) |
eGFR (ml min−1 1.73 m−2, median (IQR)) | 67.0 (45.0, 87.0) | 67.0 (47.3, 82.0) |
NT-ProBNP (ng L−1, median (IQR)) | 1,099.0 [394.0, 3,148.0] | 1,216.0 (447.8, 2,522.3) |
Ferritin and TSAT screened (n, %) | 24 (30.7) | 23 (31.9) |
Ferritin level (µg L−1, median (IQR)) | 93.0 (48.5, 167.5) | 147.5 (47.0, 230.0) |
TSAT (%, median (IQR)) | 18.0 (13.0, 33.0) | 15.0 (9.0, 25.8) |
ID in screened patients (n, %) | 16 (66.7) | 14 (60.9) |
Hb screened (n, %) | 60 (76.9) | 45 (62.5) |
Hb (g dl−1, median (IQR)) | 13.21 (11.68, 14.42) | 13.54 (11.28, 14.82) |
Anemia in screened patients (n, %) | 24 (40.0) | 17 (37.8) |
LVEF (%, median (IQR)) | 34.0 (29.0, 38.0) | 33 (28, 38) |
RV function (n, %) | ||
Normal | 51 (65.4) | 53 (73.6) |
Moderate | 25 (32.1) | 18 (25.0) |
Poor | 2 (2.6) | 1 (1.4) |
Cardiovascular history | ||
Atrial fibrilation (n, %) | 38 (48.7) | 26 (36.1) |
Hypertension (n, %) | 21 (26.9) | 24 (33.3) |
Diabetes (n, %) | 21 (26.9) | 23 (31.9) |
ICD (n, %) | 23 (29.5) | 17 (23.6) |
CRT (n, %) | 9 (11.5) | 12 (16.7) |
Cardiac surgery (n, %) | 46 (59.0) | 37 (51.4) |
Asthma (n, %) | 14 (17.9) | 10 (13.9) |
COPD (n, %) | 12 (15.4) | 9 (12.5) |
Medication use | ||
β-Blocker (n, %) | 66 (84.6) | 53 (73.6) |
RASi (n, %) | 70 (89.7) | 66 (91.7) |
ARNI (n, %) | 29 (37.2) | 35 (48.6) |
MRA (n, %) | 47 (60.3) | 49 (68.1) |
SGLT2i (n, %) | 41 (52.6) | 44 (61.1) |
